Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant PDT with 5-ALA for Colon Cancer
NCT01522677Phase 2Withdrawn
- Start
- Aug 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in colon cancer. Planned start Aug 2012; status: withdrawn.
02
Drugs
5-aminolevulinic acid
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT01522677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01522677.